Cited by 118Hormonal Regulation and HypertensionParathyroid Disorders and TreatmentsPotassium and Related Disorders

Hyperparathyroidism in Patients with Primary Aldosteronism: Cross-Sectional and Interventional Data from the GECOH Study

Open access
Pilz, Stefan, Kienreich, Katharina, Drechsler, Christiane, Ritz, Eberhard, Fahrleitner-Pammer, Astrid, Gaksch, Martin, Meinitzer, Andreas, März, Winfried +2 more·2012·The Journal of Clinical Endocrinology & Metabolism

Abstract

Context: Experimental studies suggest that aldosterone induces hypercalciuria and might contribute to hyperparathyroidism. Objective: We aimed to test for differences in PTH levels and parameters of calcium and vitamin D metabolism in patients with primary aldosteronism (PA) compared with patients with essential hypertension (EH) and to evaluate the impact of PA treatment on these laboratory values. Design, Setting, and Participants: The Graz Endocrine Causes of Hypertension study includes hypertensive patients referred for screening for endocrine hypertension at a tertiary care center in Graz, Austria. Main Outcome Measures: Differences in PTH levels between patients with PA and EH. Results: Among 192 patients, we identified 10 patients with PA and 182 with EH. PTH levels (mean ± sd in picograms per milliliter) were significantly higher in PA patients compared with EH (67.8 ± 26.9 vs. 46.5 ± 20.9; P = 0.002). After treatment of PA with either adrenal surgery (n = 5) or mineralocorticoid receptor antagonists (n = 5), PTH concentrations decreased to 43.9 ± 14.9 (P = 0.023). Serum 25-hydroxyvitamin D concentrations were similar in both groups. Compared with EH, serum calcium concentrations were significantly lower (2.35 ± 0.10 vs. 2.26 ± 0.10 mmol/liter; P = 0.013), and there was a nonsignificant trend toward an increased spot urine calcium to creatinine ratio in PA [median (interquartile range) 0.19 (0.11–0.31) vs. 0.33 (0.12–0.53); P = 0.094]. Conclusions: Our results suggest that PA contributes to secondary hyperparathyroidism. Further studies are warranted to evaluate whether PTH has implications for PA diagnostics and whether mineralocorticoid receptor antagonists have a general impact on PTH and calcium metabolism.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jc.2011-2183

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Pilz, S., Kienreich, K., Drechsler, C., Ritz, E., Fahrleitner-Pammer, A., Gaksch, M., Meinitzer, A., März, W., Pieber, T. R., & Tomaschitz, A.
Affiliations
  • Amsterdam Public Health (NL)
  • Department of Internal Medicine (S.P., K.K., A.F.-P., M.G., T.R.P., A.T.), 8036 Graz, Austria
  • University of Würzburg (DE)
  • University Hospital Heidelberg (DE)
  • Medical University of Graz (AT)
Corresponding author
  • Pilz, Stefan
  • Tomaschitz, Andreas
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2012-01-01
Volume
97
Issue
1
Pages
E75-E79
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2074546237
Cited by
118
References
21
Citations by year
2026: 6 · 2025: 5 · 2024: 4 · 2023: 5 · 2022: 8 · 2021: 8 · 2020: 14 · 2019: 10 · 2018: 7 · 2017: 7 · 2016: 6 · 2015: 10 · 2014: 9 · 2013: 8 · 2012: 11
FWCI
7.34
Type
journal article
Language
en
Open access
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • PubMed (publishedVersion)
  • Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion, other-oa)
  • Pure Amsterdam UMC (submittedVersion, other-oa)
  • Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam) (submittedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
Funders
  • Austrian Federal Ministry of Economy, Family and Youth
  • Oesterreichische Nationalbank (13905, 825329)
  • Bundesministerium für Verkehr, Innovation und Technologie
  • Steirische Wirtschaftsförderungsgesellschaft
  • Karl-Franzens-Universität Graz
  • Medizinische Universität Graz
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
  • Health Sciences › Medicine › Nephrology › Parathyroid Disorders and Treatments
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Potassium and Related Disorders
Keywords
primary aldosteronism, secondary hyperparathyroidism, parathyroid hormone, essential hypertension, mineralocorticoid receptor antagonists, adrenal surgery, hypercalciuria, vitamin D metabolism, serum calcium, endocrine hypertension
MeSH terms
Adult, Aged, Aldosterone, Blood Pressure, Clinical Trials as Topic, Cross-Sectional Studies, Data Interpretation, Statistical, Female, Follow-Up Studies, Humans, Hyperaldosteronism, Hyperparathyroidism, Hypertension, Male, Middle Aged, Parathyroid Hormone, Renin-Angiotensin System

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review